ACP Journal Club. Review: Interferon and nucleoside/tide  analogues reduce risk for hepatocellular  cancer in patients with chronic hepatitis B.
Sherker
Averell H
AH
Washington Hospital Center and Georgetown University, Washington, DC, USA.